Jenburkt Pharmaceuticals board to consider dividend

Jenburkt Pharmaceuticals has informed that a Meeting of Board of Directors of the Company is scheduled to be held on May 30, 2016, to consider and take on record the audited results for the quarter / financial year ended on March 31, 2016; and to recommend Dividend, if any.

The above information is a part of company’s filings submitted to BSE.